Michael Carducci
Physician · Johns Hopkins School of Medicine
Credentials: · · · ·
History
- 1991–1993
Medical Oncology
- 1988–1991
Internal Medicine
Research
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
New England Journal of Medicine · 2007 · 2,970 citations
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
New England Journal of Medicine · 2015 · 2,355 citations
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
New England Journal of Medicine · 2014 · 2,287 citations
- ME
105 papers
78 papers · 1 as a fellow
- SD
62 papers
- CP
52 papers · 1 as a fellow
47 papers · 1 as a fellow
34 papers
28 papers
- MM
27 papers
Grants
- 1997–2027
Regional Oncology Research Center
National Cancer Institute · P30
Project lead · $11.5M · Johns Hopkins University
- 2014–2027
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
National Cancer Institute · UM1
Contact PI · $21.9M · Johns Hopkins University
- 2020–2026
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
National Cancer Institute · U24
Contact PI · $505.3K · Johns Hopkins University
- 1995–2014
Phase I Clinical Trials of New Anti-Cancer Targeted Therapies
National Cancer Institute · U01
Contact PI · $8.4M · Johns Hopkins University
Clinical trials
- 2017–2019
Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
Principal investigator · Terminated · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2011–2015
Principal investigator · Completed · Phase 1, Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2011–2015
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Principal investigator · Completed · Phase 3
Active Biotech AB
- 2010–2012
Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)
Principal investigator · Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins